PUBLICATIONS · 22782416
Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- JAMA
- Publication date
- 2012 Jul 11
- First author
- Neoptolemos JP
This record carries publication-notice metadata. Review the notices below before relying on it.
Publication notices
- absence is not clearance
- true
- has correction metadata
- true
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- JAMA. 2012 Nov 14;308(18):1861
- note
- Source null
- related pmid
- Source null
- relationship
- Erratum in
- url
- Source null
- citation
- JAMA. 2012 Nov 14;308(18):1855; author reply 1855-6. doi: 10.1001/jama.2012.13952.
- note
- Source null
- related pmid
- 23149995
- relationship
- Comment in
Authors and identifiers
- name
- Neoptolemos JP
- type
- Author
- name
- Moore MJ
- type
- Author
- name
- Cox TF
- type
- Author
- name
- Valle JW
- type
- Author
- name
- Palmer DH
- type
- Author
- name
- McDonald AC
- type
- Author
- name
- Carter R
- type
- Author
- name
- Tebbutt NC
- type
- Author
- name
- Dervenis C
- type
- Author
- name
- Smith D
- type
- Author
- name
- Glimelius B
- type
- Author
- name
- Charnley RM
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Neoptolemos JP
- type
- Author
- name
- Moore MJ
- type
- Author
- name
- Cox TF
- type
- Author
- name
- Valle JW
- type
- Author
- name
- Palmer DH
- type
- Author
- name
- McDonald AC
- type
- Author
- name
- Carter R
- type
- Author
- name
- Tebbutt NC
- type
- Author
- name
- Dervenis C
- type
- Author
- name
- Smith D
- type
- Author
- name
- Glimelius B
- type
- Author
- name
- Charnley RM
- type
- Author
- bibliography ids
- nci-bib-45f3e2c485d1937b1d6e954a
- book metadata
- content sha256
- 83e7edc35c08d8aa3c9f57ea1a2abde9d53dbc0a57735ce70f058bb40acf7f45
- document type
- citation
- dois
- 10.1001/jama.2012.7352
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:22782416
- immutable id
- pubmed:22782416@83e7edc35c08d8aa3c9f57ea1a2abde9d53dbc0a57735ce70f058bb40acf7f45
- journal
- abbreviation
- JAMA
- issn electronic
- 1538-3598
- issn print
- 0098-7484
- issue
- 2
- name
- JAMA
- nlm unique id
- 7501160
- pages
- 147-56
- volume
- 308
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- true
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- JAMA. 2012 Nov 14;308(18):1861
- note
- Source null
- related pmid
- Source null
- relationship
- Erratum in
- url
- Source null
- citation
- JAMA. 2012 Nov 14;308(18):1855; author reply 1855-6. doi: 10.1001/jama.2012.13952.
- note
- Source null
- related pmid
- 23149995
- relationship
- Comment in
- outcomes validated
- false
- pmid
- 22782416
- provenance
- batch id
- 1e3045de9f47a5ccd566
- provider
- NCBI PubMed ESummary
- record sha256
- a00de6633147c83603b792ea0b34c91a65977f3070d8f8d34d0c58e2579e5d59
- response sha256
- 0c42e87ee821aef9d804e2d77dfdba8876f375111db163986dd22ba43a3d6a52
- retrieved at
- 2026-09-09T23:46:50.128287+00:00
- publication date
- display
- 2012 Jul 11
- precision
- day
- year
- 2012
- publication types
- Clinical Trial, Phase III
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial.
Preserved source evidence · Not medical advice
Triangle